Professional activities

- Academic in Residence, National Measurement Lab

The National Measurement Lab (NML) is the UK’s designated institute for chemical and bio-measurement, standardising physical, chemical, and biological measurements. Appointed as Academic in Residence in 2023, Dr Liptrott works in collaboration with NML to advance knowledge on translating advanced therapeutics and complex medicines through metrology and measurement science.

- Chair of the European Technology Platform for Nanomedicine working group on Nanomedicine Safety and Characterisation

The working group supports the development of nano-enabled products and applications in medicine across the development pipeline. By addressing safety issues from the earliest stages, the working group promotes the successful translation of nanomedicine from development to implementation.

- Trustee of the British Society for Nanomedicine

The British Society for Nanomedicine was created at the University of Liverpool to allow industry, academia, clinicians, and the public open access to news and details of ongoing research throughout the UK.

- Vice Chair of the British Toxicology Society Scientific subcommittee, and member of the Executive Committee

Some of the main objectives of the BTS are to organise scientific meetings and conferences, foster interactions and facilitate collaborative meetings with other societies, and support scientific discussions across its membership. The Scientific Subcommittee (SSC) is responsible for agreeing and organising the BTS scientific meetings programmes, inviting contributors and presenters to these meetings and discussions, and fostering collaborations with the wider toxicology community.

- The Pandemic Institute Internal Scientific Advisory Panel (ISAP)

I support TPI in achieving continued scientific focus and relevance within the consortium.

- CELT Biocompatibility Lead

Within the Centre of Excellence for Long-acting Therapeutics, we oversee the safety and compatibility assessment of novel technologies for long-acting therapy (LAT) applications. Critical consideration must be given to the route of administration and release profiles, as well as the administration site response of LATs. To do this, we utilise our existing, extensive assay cascade, which has been the subject of numerous interlaboratory comparisons. Additionally, we have developed novel 3D models to replicate administration site responses more appropriately.
___________________________________________________________________________________

Previous roles/appointments:

|| Board member of the Liverpool City Region Health and Life Sciences Board ||

The LCR LEP has created several sub-boards and advisory groups to provide access to extensive knowledge and expertise across the City Region. The sub-boards are focused on sectors of the economy that have been identified as having growth potential, plus Innovation and Enterprise. These groups made up of leaders from business and the public sector, provide strategic insight, intelligence, and guidance to the LEP Board and the LEP Executive in fulfilling their strategic activities for the City Region. Their importance and strength is in their detailed technical and specialist expertise, based on practical business experience, which provides information and intelligence to inform economic strategy and effective delivery. Currently, I am a member of the R&D, biopharmaceuticals, and skills sub-groups.

|| - Knowledge Exchange Steering Group (KESG), Knowledge Exchange Lead forPersonalised Health

The KESG brings together KE leaders in university research themes (Advanced Materials, Climate Futures, Digital, Heritage, Infectious Disease, Personalised Health, Starting Well, Living Well, and Aging Well) and KE centres (like the MIF, DIF, CEIDR and Heseltine) to support and oversee the university’s ambition, activity, and funds in knowledge exchange. The KESG oversees KE plans in each of the university’s research theme areas, identifies synergies between different areas of activity, and provides a forum for discussion of large-scale KE opportunities and partnerships. The KESG has members of all three faculties and will also oversee and allocate our pump priming funds (such as the Partnership, Recovery and Resilience fund) and funds for developing KE strands of our research themes and the associated partnerships (resourced from HEIF). The KESG will also influence, where possible, the development of international, national and local R&D and innovation strategy

Selected Professional Activities

Conference Role

Biosafety and Nanotoxicology at Nanomed Europe 2023 (NME23), Keynote/Plenary by Invitation (University of Liverpool, 2023) (Conference Role)
Measuring & Modulating Immunogenicity of LNP-Payload Composition at Understanding Immune Responses Linked to Physio-Chemical Characteristics of Non-Viral Delivery Systems, by Invitation (Boston, MA, USA, 2022) (Conference Role)

Editorship

Toxicology (Invited Co-editor, 2024 - present) (Editorship)

External Administrative or Committee Role

Chair, Working Group on Nanomedicine Safety and Characterisation, Invited (European Technoloy Platform for Nanomedicine, 2023 - present) (External Administrative or Committee Role)
Academic in Residence, Invited (National Measurement lab, 2023 - present) (External Administrative or Committee Role)
Co-leader, Nanomedicines Focus Group (2022 - present) (External Administrative or Committee Role)

Professional Body Membership

Royal Society of Biology (Fellow, 2022 - present) (Professional Body Membership)
British Toxicological Society (Member, 2019 - present) (Professional Body Membership)
British Pharmacological Society (Member, 2019 - present) (Professional Body Membership)
British Society for Immunology (Affiliate, 2004 - present) (Professional Body Membership)

Conference Roles

Safety assessment of cellular and advanced therapies at Deciphering immune responses to complex medicines using advanced in vitro models, by Invitation (2025)
Biosafety and Nanotoxicology at Nanomed Europe 2023 (NME23), Keynote/Plenary by Invitation (University of Liverpool, 2023)
Benefits of integrating sex-gender analysis into research in emerging fields at Gendered interactions between diversity and quality in research. Science knowledge for equitable and just future, Keynote/Plenary by Invitation (Salzburg, 2022)
Measuring & Modulating Immunogenicity of LNP-Payload Composition at Understanding Immune Responses Linked to Physio-Chemical Characteristics of Non-Viral Delivery Systems, by Invitation (Boston, MA, USA, 2022)
Advanced Therapy Medicinal Products (ATMP) at Interactions between the immune system and Nano(bio)materials - linking PCC to Biological effects, by Invitation (Belfast, 2022)
“Application of Nanotechnology in Drug Delivery", by Invitation (University of Surrey, 2014)
“Use of in vitro testing for assessing the immunogenicity of nanomaterials”, by Invitation (University of Keele, 2014)
“New Approaches to antiretroviral drug delivery”, by Invitation (CROI Foundation, 2013)
“Application of flow cytometry to nanoparticle characteristics and protein binding", by Invitation (London Research Institute, Cancer Research UK , 2013)
CLINAM, by Invitation (2018 - 2019)
Nanomed 2018 (26-28th June 2018), Manchester, by Invitation (2017 - 2018)
EuPAT 9 The Ninth pan-European Conference on PAT and QbD Sciences (15-16th may 2018), Manchester, by Invitation (2017 - 2018)
7th APS International PharmSci Conference (University of Strathclyde, UK, 5th-7th September 2016), by Invitation (2016 - 2017)
by Invitation (2016 - 2017)
ATREUM Conference, by Invitation (2016 - 2017)
CYTO 2017 (Hynes Convention Centre, Boston, MA, USA, 10th-14th June 2017), by Invitation (2016 - 2017)
Keele Nanopharmaceutics Symposium (Keele University, Keele, UK 21-22 September 2015) , by Invitation (2015 - 2016)
Nanoparticles for cell tracking workshop (Liverpool, UK 21-22 September 2015) , by Invitation (2015 - 2016)
British Society for Antimicrobial Chemotherapy Antibiotic Resistance and Mechanisms Workshop, by Invitation (2015 - 2016)
1st Joint Nanomedicine Society meeting (Grenoble, France, 7-9th December 2015) , by Invitation (2015 - 2016)
7th APS International PharmSci Conference (University of Strathclyde, UK, 5th-7th September 2016), by Invitation (2015 - 2016)
2nd UKRMP meeting on Nanoparticles for Stem Cell Tracking (Liverpool, UK, 21-22nd September 2015) , by Invitation (2015 - 2016)
Preclinical modelling workshop (University of Keele, February 27-28th 2014), by Invitation (2014 - 2015)
Research Seminar Series (University of Northumbria, 27th February 2015) , by Invitation (2014 - 2015)
Modular Training Programme In Applied Toxicology (University of Surrey, June 9-13th), by Invitation (2014 - 2015)
20th Conference on Retroviruses and Opportunistic infections (Atlanta, Georgia, USA, March 2013) , by Invitation (2012 - 2013)
Cancer Research UK (London Research Institute, Cancer Research UK (London, UK), by Invitation (2012 - 2013)

Editorships

Toxicology (Invited Co-editor, 2024 - present)
Nature Nanotechnology (Invited Peer reviewer)
Nature Biomedical Engineering (Peer reviewer, 2017 - present)
Nanomedicine: Nanotechnology, Biology and Medicine (Peer reviewer, 2012 - present)
The Lancet Eclinicalmedicine (Invited Reviewer)
EMBO Molecular Medicine (Invited Reviewer)
British Journal of Pharmacology (Peer Reviewer, 2014 - present)
Journal of Interdisciplinary Nanomedicine (JOIN) (Senior Editor, 2018 - present)
British Journal of Clinical Pharmacology (Peer reviewer, 2011 - present)
Antimicrobial Agents and Chemotherapy (Peer reviewer, 2009 - present)
Journal of Antimicrobial Chemotherapy (Peer reviewer, 2008 - present)

Event Roles

NanoMed Europe 2023, Keynote/Plenary (Talk/Lecture, 2023)

Examination Roles

Vrije Universiteit Brussel, PhD (2024)
University of Liverpool, Molecular and Clinical Cancer Medicine (PhD, 2024)
University of Liverpool, Pharmacology and Therapeutics (PhD, 2024 - present)
Swansea University, Microneedle development for therapeutic delivery (PhD, 2021)
University of Liverpool, PhD viva of Arun Tailor (2018)
University of Liverpool, PhD viva of Louise Tidbury; internal examiner (2017)
University of Liverpool, PhD viva of Rajith Kumar Reddy; internal examiner (2017)

External Administrative or Committee Roles

Chair, Working Group on Nanomedicine Safety and Characterisation, Invited (European Technoloy Platform for Nanomedicine, 2023 - present)
Academic in Residence, Invited (National Measurement lab, 2023 - present)
Co-leader, Nanomedicines Focus Group (2022 - present)
Member of the Liverpool LEP Health & Life Sciences Board, Invited (Liverpool City Council, 2022 - present)

Grant Application Assessments

External Post-submission (Canada Foundation for Innovation, 2023)
External Post-submission (Medical Research Council (MRC))
External Post-submission (Medical Research Council (MRC), 2022 - present)
External Post-submission (British Heart Foundation, 2022 - present)
External Post-submission (Biotechnology and Biological Sciences Research Council (BBSRC), 2014 - present)
External Post-submission (European Commission, 2020 - present)
External Pre-submission (National Science Center, 2021)
External Post-submission (Carnegie Trust for the Universities of Scotland, 2015 - present)
Internal Pre-submission (2021)

Internal Administrative or Committee Roles

Knowledge Exchange (KE) lead for Personalised Health (Faculty, 2021 - present)
Vice Chair Research Ethics Committee (ISMIB) (School / Institute, 2020 - present)
Nanomedicine Strand Convenor (MRes Biomedical Sciences and Translational Medicine) (University, 2018 - 2025)
Research Ethics Committee reviewer (University, 2017 - 2018)

Organisations I have been associated with

Nattional Measurement Laboratory (2019 - present)
Infection Innovation Consortium (iiCON) - Platform Manager (Nanotherapeutics) (2021 - present)
Centre of Excellent in Long-Acting Therapeutics (CELT) (2021 - present)
Liverpool Nanotherapeutics Hub (NTH) (2019 - present)
European Nanomedicine Characterisation Laboratory (2014 - present)
NIHR National Biomedical Research Centre (2008 - 2010)

Professional Body Memberships

Royal Society of Biology (Fellow, 2022 - present)
British Toxicological Society (Member, 2019 - present)
British Pharmacological Society (Member, 2019 - present)
British Society of Nanomedicine (Executive Committee Member, 2011 - present)
British Society for Immunology (Affiliate, 2004 - present)